The Walrus Talks is a national series of events about Canada and its place in the world. Each event offers thoughtful, inspiring thinking from scholars, writers, performers, scientists, artists, and business leaders.
Questions about the Walrus Talks? Read our FAQ here.
General admission: $20
Canadian Museum of Nature
240 McLeod St.
Exploring innovation in health and medicine. Building health care for the future.
- Rohit Khanna, founder & managing director, Catalytic Health
- Maureen O’Neil, president, Canadian Foundation for Healthcare Improvement
- Karl Mallory, jurisdictional lead, Closing the Circle of Care Expansion Project
- Jessica Ching, co-founder and CEO, Eve Medical
- Kona Williams, forensic pathologist, Ontario Forensic Pathology Service
- Steven Narod, Canada Research Chair in Breast Cancer
- Brendan Frey, co-founder and CEO, Deep Genomics
Rohit Khanna is the founder and managing director of Catalytic Health, a health care communications agency in Toronto. He holds a BA from McGill University, an MBA from Queen’s University’s School of Business, and MSc. from the London School of Economics and Political Science, and is completing his MPH in epidemiology from the Harvard School of Public Health. Khanna is also a former mentor for Harvard’s Health Acceleration Challenge. He speaks and writes on a range of health care topics.
Maureen O’Neil is president of the Canadian Foundation for Healthcare Improvement, former president of the International Development Research Centre, and a former deputy minister of citizenship in Ontario. Maureen has chaired several boards, both in Canada and internationally, including a university board of governors, several think tanks, and a provincial agency responsible for electronic health systems. In June 2011, she was named an officer of the Order of Canada.
Karl Mallory has been supporting advances in digital health and integration for over a decade. He collaborates with federal, provincial, and First Nation organizations across Canada to improve access to digital-health tools and electronic health records for First Nation health centres, their patients, and their health care partners. Enabling First Nation community members with access to their health records is a priority in Karl’s work.
Jessica Ching is the co-founder and CEO of Eve Medical, which she founded after graduating from OCAD University in the hopes of integrating design and health care. She and her team brought a self-sampling device for molecular testing (HerSwab) and a home diagnostic platform (Evekit.com) from early concept to commercial launch. Eve Medical was a finalist for the Genentech Quest Award, and the MIT Technology Review named the organization a women’s tech company to watch.
Kona Williams is a forensic pathologist and coroner with the Ontario Forensic Pathology Service. She completed her medical degree at the University of Ottawa, followed by a residency in anatomical pathology and then a fellowship in forensic pathology at the University of Toronto. She is Cree and Mohawk and currently the only First Nations forensic pathologist in Canada. She holds a second-degree black belt in karate.
Steven Narod is a Canada Research Chair in Breast Cancer, a professor at the Dalla Lana School of Public Health and the Department of Medicine at the University of Toronto, and a senior scientist at Women’s College Research Institute. He has shaped our knowledge of risk assessment for breast and ovarian cancer and has found ways to reduce mortality among women with BRCA1 and BRCA2 mutations. In 2012, Steven became a fellow of the Royal Society of Canada, and in 2016 he won both the Killam Prize and the Basser Global Prize.
Brendan Frey is internationally recognized for laying foundations in the fields of machine learning and genome biology. He published over a dozen papers on these topics in Science Nature, and Cell, including one of the first papers on deep learning. He holds numerous awards and is a fellow of the Royal Society of Canada. His work focuses on the use of machine learning to interpret genetic data and to detect and treat genetic disease.